Skip to main content

Peer Review reports

From: GNUV201, a novel human/mouse cross-reactive and low pH-selective anti-PD-1 monoclonal antibody for cancer immunotherapy

Original Submission
18 Oct 2023 Submitted Original manuscript
23 Oct 2023 Author responded Author comments - Donggoo Bae
Resubmission - Version 2
23 Oct 2023 Submitted Manuscript version 2
8 Nov 2023 Reviewed Reviewer Report
21 Nov 2023 Reviewed Reviewer Report
6 Dec 2023 Author responded Author comments - Donggoo Bae
Resubmission - Version 3
6 Dec 2023 Submitted Manuscript version 3
6 Dec 2023 Author responded Author comments - Donggoo Bae
Resubmission - Version 4
6 Dec 2023 Submitted Manuscript version 4
15 Dec 2023 Reviewed Reviewer Report
18 Dec 2023 Reviewed Reviewer Report
22 Jan 2024 Author responded Author comments - Donggoo Bae
Resubmission - Version 5
22 Jan 2024 Submitted Manuscript version 5
2 Feb 2024 Author responded Author comments - Donggoo Bae
Resubmission - Version 6
2 Feb 2024 Submitted Manuscript version 6
12 Feb 2024 Author responded Author comments - Donggoo Bae
Resubmission - Version 7
12 Feb 2024 Submitted Manuscript version 7
Publishing
13 Feb 2024 Editorially accepted
11 May 2024 Article published 10.1186/s12865-024-00609-z

You can find further information about peer review here.

Back to article page